Surefire Medical, Inc. CEO and leadership

Mary Szela is a highly accomplished senior executive with 25 years of progressive leadership roles in the life sciences industry.

Dr. Chomas received his Bachelor’s of Science in Engineering from Duke University and completed doctoral training at the University of Virginia, investigating the use of ultrasound in breast cancer characterization. He has 12 years experience in developing devices from initial concept through pre-clinical trials and clinical trials, and he has authored 17 patents in medical devices. In five years with Siemens Ultrasound as Senior Engineering Manager, Dr. Chomas led a team of engineers and released six product features. Most recently, Dr. Chomas was the Director of Research at Cabochon, where he led the engineering team in the research, development and pre-clinical testing, which ultimately culminated in a 35-patient clinical trial.

Aravind Arepally is a Division of Interventional Radiology, Piedmont Healthcare, Atlanta, GA at Piedmont Healthcare and Chief Scientific Officer at Surefire Medical and is based in Baltimore Maryland Area. He has worked as Associate Professor of Radiology at Johns Hopkins University School of Medicine/The. Aravind works or has worked as Director:Clinical at Johns Hopkins. He attended Emory University School of Medicine between 1989 and 1993 and MERCER UNIVERSITY.

Robert Holburn, Jr. has more than 35 years in senior financial management positions in private and public technology companies. For the last 10 years he held the position of Vice President and CFO of Medivance, Inc., a medical device manufacturer. Prior to joining the Surefire Medical team, Mr. Holburn also served as President, Chief Operating Officer of IPSeal, a venture capital backed telecommunications company; Vice President, CFO of Solant, Inc.; Vice President, CFO of Rogue Wave Software. He has extensive tenures with Advanced Power Technology and Texas Instruments. Mr. Holburn holds an MBA from The College of William and Mary and a Bachelors of Science degree from the University of Rhode Island and was a commissioned officer in the United States Army.

Dan Estay is a Chief Business Officer at Surefire Medical.

Dr. Chomas received his Bachelor’s of Science in Engineering from Duke University and completed doctoral training at the University of Virginia, investigating the use of ultrasound in breast cancer characterization. He has 12 years experience in developing devices from initial concept through pre-clinical trials and clinical trials, and he has authored 17 patents in medical devices. In five years with Siemens Ultrasound as Senior Engineering Manager, Dr. Chomas led a team of engineers and released six product features. Most recently, Dr. Chomas was the Director of Research at Cabochon, where he led the engineering team in the research, development and pre-clinical testing, which ultimately culminated in a 35-patient clinical trial.

Aravind Arepally is a Division of Interventional Radiology, Piedmont Healthcare, Atlanta, GA at Piedmont Healthcare and Chief Scientific Officer at Surefire Medical and is based in Baltimore Maryland Area. He has worked as Associate Professor of Radiology at Johns Hopkins University School of Medicine/The. Aravind works or has worked as Director:Clinical at Johns Hopkins. He attended Emory University School of Medicine between 1989 and 1993 and MERCER UNIVERSITY.

Mary Szela is a highly accomplished senior executive with 25 years of progressive leadership roles in the life sciences industry.

Dr. Chomas received his Bachelor’s of Science in Engineering from Duke University and completed doctoral training at the University of Virginia, investigating the use of ultrasound in breast cancer characterization. He has 12 years experience in developing devices from initial concept through pre-clinical trials and clinical trials, and he has authored 17 patents in medical devices. In five years with Siemens Ultrasound as Senior Engineering Manager, Dr. Chomas led a team of engineers and released six product features. Most recently, Dr. Chomas was the Director of Research at Cabochon, where he led the engineering team in the research, development and pre-clinical testing, which ultimately culminated in a 35-patient clinical trial.